With volume procurement and catalog adjustment background of the pharmaceutical market book with the text, car derailment

The results of the third batch of drugs in Wen/Code Wanxuan scared many pharmaceutical practitioners.
the catalogue is under way and seems to give some people hope of preserving their share of the stock or entering the stock ecology.
, with volume procurement and catalog adjustment will enter the stage of stock reform.
this article, we talk about some callous analysis of pharmaceutical business, retail pharmacies, auxiliary drugs, health care products and other related subjects.
sure that all of these subjects will survive in the age of great health, but without exception, after a chill.
price should I make for complementary medication? Who is the auxiliary drug? In the author's breakfast experience, soy milk, oil bars, buns are corresponding to the price, but pickles, paper towels are not charged.
is it callous to make such a analogy? Auxiliary medication should not be charged, which is ideal and can also be supported by theory.
, however, it has been suggested that one of the complementary medications has a nutritional health effect and the other has a certain clinical therapeutic effect.
such a voice brings the problem to the complexity, but also to the substance of further dialectical discussion.
First of all, auxiliary drugs and health care products are bounded, which directly determines whether the relevant products can, should not be sold in the hospital, use, we recommend that health care products-type auxiliary drugs "one-size-fits-all" from the hospital, or at least to list the key monitoring list, it is necessary for hospital doctors to give patients informed tips.
second, for the hospital doctors think that there is a certain clinical therapeutic role of auxiliary drugs, of course, not suitable for direct administrative intervention of the coercive measures to be withdrawn.
but the medical reform is relatively thorough and thorough in some areas, some hospitals should do something spontaneously.
such as around low-cost drugs, with the purchase of drugs, strengthen clinical treatment path and prescription review control, to recommend standards, the establishment of mechanisms.
Once there is a significantly high price of auxiliary drugs, there is a contradiction in the relationship between price, and obviously has unreasonable use, use of the scene, regardless of whether or not there is a certain clinical therapeutic role of auxiliary drugs into the regulatory authorities and reported the scope of the incident.
price should I have for health care products? Where can I act as a channel? There is no false definition of the price of health care products, if the concept of luxury goods to look at, some health care products prices can be pushed up to sky-high prices, which is not a simple cost audit problem, but the market value of the circulation of the problem.
is not a matter for price regulators, but for consumers.
Of course, the relevant administrative supervision departments and peers to report, the public report is still very necessary, have the right to keep an eye on the illegal perpetrators of crimes, such as quality and safety, business qualifications, infringement and occupation, economic bribery and other issues.
health care products related practitioners because of the relatively relaxed business environment, can be dynamic design, independent development, for all their decision-making and behavior responsible for planning.
class B over-the-counter drugs are still the category of drugs, but to expand further is a huge and complex survival competition for health care products.
this reflects not only the different tracks of health care products and medicines, but also the complex stratifying and classification within health care products.
Retail pharmacies as a natural partners in health care products, it is bound to deal with two business models of health care products: one is efficiency first, dare to kill prices to enter the market to compete for health care products enterprises, products, although not applicable to drug belt procurement, but related enterprises, products in the pursuit of "quantity price linkage", to volume for retail pharmacies to bring abundance Pei customers; one is the concept of first, dare to conservatively set a higher price limit unlimited profit-oriented enterprises, products, pharmacies by the drug belt procurement, health insurance personal account reform, medical insurance basic drug strict management and other policies under pressure, there is every reason, the right to embrace a higher commission of the 1st category of health care products for sale, wish them prosperity.
Retail pharmacies and the pharmaceutical business are facing a difficult time If retail pharmacies introduce the consumption of medicines purchased with a belt, in order to ensure profits, do some price increases (currently generally 15%), may fluctuate around 15% or less in the future.
Because of the increase, the number of drug patients who choose to go to retail pharmacies to buy drugs is small, but this reduction in traffic is not related to the health care sector, pharmacies all behavior to be self-destruction.
at a time when health care payment standards have not yet been determined, we are seeing the urgency of establishing standards for pharmacies to increase the amount of medicines they purchase.
15% is actually a value taken from the head, which logically does not match the pharmacy's interests, and technically lacks segmentation categories and model calculations.
increased with-on-the-go procurement coverage, we foresee the application of this standard to the outflow of prescriptions for end-of-hospital medicines.
pharmaceutical business in China is not only the distribution of drugs so simple, but also involved in advance capital, control and marketing and other complex, responsible role.
procurement mechanism has ignored the domination of hospitals and pharmacies, and certainly does not regard the pharmaceutical business as an unbreakable fortress.
other words, the era of pharmaceutical business as a bastion of commerce has lost its monopoly advantage as the rear has been drawn from the bottom of the kettle.
the pharmaceutical business giant's services have also been picked up in the strategic purchase of services with volume procurement.
means that the pharmaceutical business for the distribution of a large quantity of drugs, do not allow less service, also do not allow privately increase the content of the service, the need to provide a standard interface of quality services.
means that pharmaceutical giants have a similar competitive position to local and medium-sized pharmaceutical businesses.
Pharma market or ushered in a major wash, to alleviate external worries in the pharmaceutical business, retail pharmacies, auxiliary drugs, health care products, these with the concept of fast-disappearing between the main body, pharmaceutical e-commerce is an unstoppable, irreversible troublemaker.
Pharma e-commerce brings new competition, new connotation and new efficiency to the pharmaceutical business, forcing all pharmaceutical businesses that play the role of channel and channel to either expand the monopoly chain and have depth;
Retail pharmacies may become long-term fragrances, because retail pharmacies in the aging society, community medical direction of the existing traffic, in the volume of procurement, health care products selection will have a more efficient, more diverse battlefield.
with everyone spitting slot retail pharmacies, while finding that retail pharmacies are not only to make changes to adapt to the times, retail pharmacies "boat small good turn."
the biggest advantage of pharmaceutical e-commerce and pharmaceutical business is nothing more than organizational strength and replication power.
against the background of retail pharmacies constantly showing their own personality, availability and versatility, all pharmaceutical businesses are cause for concern because of the horizontal competition of new forces and the interest game of upstream and downstream.
including pharmaceutical e-commerce, the pharmaceutical business should be respected only for providing services and efficiency to the end end.